Skip to main content
. 2015 Sep 13;2015:295925. doi: 10.1155/2015/295925

Figure 4.

Figure 4

Functional recovery and mortality after focal cerebral ischemia. (a) Low-dose fimasartan improved functional recovery after transient focal ischemia compared to PBS-controls with MCAO. This improvement was prominent at 14 days after ischemia (P < 0.05; n = 17 for 0.5 mg/kg and n = 12 for control). (b) The mortality rate decreased significantly in the low-dose fimasartan group compared with PBS-controls with MCAO (P by log-rank test < 0.05; n = 18 each).